Most founders run from hard markets. Robert Page kept circling back to the same one.
Today Robert Page runs Pulse Protocol, a Los Angeles company that most people will never see and many patients quietly depend on. It is a B2B software and marketing platform for the medical-travel business: the rails that turn a stranger's inquiry into a matched provider, a scheduled appointment, a processed payment, and a follow-up. Clinics and facilitators plug in; the busywork gets automated; the demand becomes something a small team can actually manage.
That is the current shape of a problem Page has been working since 2000. He is, by temperament, an infrastructure person in an industry that prefers to sell miracles. While other health-tech founders chase the dramatic before-and-after, Page has built three companies on the least romantic promise in the category - a price you can read, a provider somebody actually vetted, and an option for people who were told they had none.
What we're doing is opening the door for people that are underserved in the United States or Canada.— Robert Page, on launching MedRepublic
The arc is unusually consistent. First he was a facilitator, learning the trade hands-on with MedToGo International. Then he tried the consumer side, building MedRepublic into a curated marketplace that connected patients with screened doctors across Mexico, the Cayman Islands and Costa Rica. Now, with Pulse Protocol, he has gone underneath the whole thing - selling the software backbone rather than the trip itself. Same destination, three different vehicles.
A boring idea on a flashy stage.
In 2016, MedRepublic was named among TechCrunch Disrupt's top 25 new tech companies and walked onto a stage built for hype. The pitch was not hype. It was a vetted list, a transparent price, and a market Page sized at more than ten billion dollars a year - a number plenty of investors quietly underestimated. The company was backed by Silicon Valley venture capital and graduated from the Amplify LA accelerator the same year.
The platform's whole reason to exist was to delete the worst part of seeking care abroad: the research. Instead of a patient gambling on a clinic found through a search engine and a leap of faith, MedRepublic offered "highly curated and vetted" providers and a clearer path. Page never oversold the certainty of it, either. He was blunt about the realities of any procedure and pointed people toward insurance and the right providers rather than pretending risk away.
MedToGo
The apprenticeship. A medical-travel facilitator where Page learned the trade from the inside out.
MedRepublic
The marketplace. Curated providers, transparent pricing, and a TechCrunch Disrupt top-25 nod.
Pulse Protocol
The rails. B2B SaaS that runs patient matching, coordination, payments and marketing for providers.
Transparency is the product.
His public bio describes him as "a relentless enthusiast for quality control, transparent pricing, and patient advocacy." Read that twice and notice what's missing: no moonshot language, no promise to reinvent medicine. The conviction is narrower and harder to fake - that an industry built on opacity can be made legible, and that legibility is itself a service worth charging for.
It explains the pivots. A facilitator can help one patient at a time. A marketplace can help thousands. But the software underneath an entire industry can change the default for everyone who never even hears Page's name. He kept moving up the stack not because the previous idea failed, but because each rung let the same belief reach further.
Anytime you enter into a surgical relationship, there's a risk.
That line is worth keeping. It's the opposite of a sales pitch, delivered by the person doing the selling. In a category crowded with guarantees, Page's credibility comes partly from refusing to offer one.
Twenty-five years, one obsession.
Begins working in global health and medical travel.
Earns his undergraduate degree at Georgetown University.
Founds MedRepublic in the Los Angeles area - the company that becomes Pulse Protocol.
MedRepublic launches publicly, lands in TechCrunch Disrupt's top 25, and graduates from Amplify LA.
Reorients toward Pulse Protocol, a B2B platform for medical-travel businesses.
Leads Pulse Protocol as CEO, focused on patient management, payments and marketing for providers.
Small things that explain a lot.
He's been in global health since 2000 - longer than many of today's health-tech founders have been out of school.
His social handles still read "medrepublic" - a fossil of his best-known venture that he never bothered to bury.
He's a three-time published author, all on the unglamorous mechanics of medical travel.
MedRepublic shared a Disrupt stage in an era when startups were chasing far flashier ideas than transparent pricing.
The links.
Sources: medicaltourism.com, healthcarerevolution.com, TechCrunch, Crunchbase, LinkedIn, Amplify LA. Facts only; gaps left blank.